[Federal Register Volume 75, Number 33 (Friday, February 19, 2010)]
[Notices]
[Pages 7483-7484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3227]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health

[[Page 7484]]

Services Administration's (SAMHSA) Drug Testing Advisory Board (DTAB) 
will meet on March 8, 2010.

    The meeting is open to the public and will include discussion of 
the Mandatory Guidelines for Federal Workplace Drug Testing 
Programs, including implementation of the revised Mandatory 
Guidelines; Federal drug testing updates from the Department of 
Transportation (DOT), the Department of Defense, and the Nuclear 
Regulatory Commission; review of significant changes in the revised 
Mandatory Guidelines; review of the National Laboratory 
Certification Program planned implementation of the revised 
Mandatory Guidelines; an update on the revised Federal Custody and 
Control Form; a review of the special proficiency testing program 
for initial and confirmation testing for new analytes and new 
cutoffs; an update on instrumented initial test facilities; an 
update on the DTAB working groups; and a comparison of HHS and DOT 
urine collection requirements.
    DTAB members and invited presenters will participate in this 
meeting through remote internet connection. On-site attendance by 
the public will be limited to space available. The meeting can also 
be accessed by the public via teleconference. To obtain 
teleconference call-in numbers and access codes, to make 
arrangements to attend on-site, or to request special accommodations 
for persons with disabilities, please register at the SAMHSA 
Committees' Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or communicate with DTAB's Program 
Assistant, Ms. Giselle Hersh (see contact information below).
    SAMHSA would like to ensure that advisory committee meetings 
proceed in an orderly fashion, are conducted in a safe and secure 
environment, that the right of free speech is protected, and that 
the ability of SAMHSA Advisory Committees to accomplish their 
objectives is not disrupted. Therefore, the following procedures 
will be followed at all DTAB meetings:
    <bullet> Attendees are subject to security screening, including 
identification (driver's license) review, metal detector screening, 
and inspection of briefcases, packages, etc. Each attendee will be 
issued a security badge that must be worn at all times while in the 
building.
    <bullet> Any interested person who wishes to be assured of the 
right to make an oral presentation during the Public Comment portion 
of the DTAB meeting must register with Ms. Hersh before the meeting.
    <bullet> Those who have not registered before the meeting will 
only be invited to speak at the discretion of the Chair and should 
submit their request to the Designated Federal Official on the day 
of the meeting.
    <bullet> Public Comment participants who are designated to speak 
may be questioned only by the Chair or DTAB members.
    <bullet> Audience members may not present comments or questions 
to DTAB members unless recognized by the Chair.
    <bullet> Attendees at the meeting are asked to maintain order 
and not display behavior that is disruptive to the meeting (i.e., 
shouting from the audience, loud outbursts).
    <bullet> We ask that attendees not approach the DTAB table area 
during the meeting without permission from the Chair or the 
Designated Federal Official.
    <bullet> The DTAB Chair or Designated Federal Official will note 
on the record any disruptive behavior and will ask the person to 
cease the behavior or else leave the meeting room.
    Substantive program information, a summary of the meeting, and a 
roster of DTAB members may be obtained as soon as possible after the 
meeting, either by accessing the SAMHSA Committee Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or by contacting Ms. Hersh. 
The transcript for the meeting will also be available on the SAMHSA 
Committee Web site within three weeks after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Drug Testing Advisory Board.
    Date/Time/Type: March 8, 2010 from 10 a.m. to 4:45 p.m. EST: 
Open.
    Place: Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry 
Road, Rockville, Maryland 20857.
    Contacts:
Ms. Giselle Hersh, Program Assistant, SAMHSA Drug Testing Advisory 
Board, 1 Choke Cherry Road, Room 2-1042, Rockville, Maryland 20857, 
Telephone: 240-276-2600, Fax: 240-276-2610, E-mail: 
<a href="/cdn-cgi/l/email-protection#30775943555c5c551e78554243587043515d5843511e5858431e575f46"><span class="__cf_email__" data-cfemail="185f716b7d74747d36507d6a6b70586b7975706b793670706b367f776e">[email protected]</span></a>.
Donna M. Bush, PhD, Designated Federal Official, SAMHSA Drug Testing 
Advisory Board, 1 Choke Cherry Road, Room 2-1033, Rockville, 
Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610.

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 2010-3227 Filed 2-18-10; 8:45 am]
BILLING CODE 4162-20-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>